Genetic screening: Triumphs, problems, and controversies

Journal of Public Health Policy

Volumn 12, Issue 4, 1991, Pages 475-491

  Natowicz, Marvin R ^a,b   Alper, Joseph S ^c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; CYSTIC FIBROSIS; DNA FINGERPRINTING; GENETIC SCREENING; HUMAN; PHENYLKETONURIA; TAY SACHS DISEASE;

CARRIERS; COSTS AND BENEFITS; EVALUATION; GENETIC DISORDERS; GENETICS AND REPRODUCTION; PROGRAM DESCRIPTIONS; RISKS AND BENEFITS; SOCIAL DISCRIMINATION;

COST-BENEFIT ANALYSIS; CYSTIC FIBROSIS; DNA FINGERPRINTING; GENETIC COUNSELING; GENETIC DISEASES, INBORN; GENETIC SCREENING; HUMAN; PHENYLKETONURIAS; PROGRAM EVALUATION; TAY-SACHS DISEASE;

EID: 0026586279     PISSN: 01975897     EISSN: 1745655X     Source Type: Journal    
DOI: 10.2307/3342559     Document Type: Editorial

References (32)

1. Committee for the Study of Inborn Errors of Metabolism (CSIEM). “Genetic Screening: Program, Principles, and Research.” Washington, D.C.: National Academy of Sciences, 1975.
2. Cohen, F. Clinical Genetics in Nursing Practice. Philadelphia: Lippincott, 1984, pp. 151-79
3. Blom, W., Huijmans, G. M., and van den Berg, G. B. “A Clinical Biochemist’s View of the Investigation of Suspected Inherited Metabolic Disease,” J. Inker. Metab. Dis. 12 (1989): 64-88.
4. Charrow, J., Nadler, H. L., and Evans, M. I. “Prenatal Diagnosis and Therapy,” in Emery, A.E.H. and Rimoin, D. L., eds. The Principles and Practice of Medical Genetics. New York: Churchill Livingstone, 1990, pp. 1959-93*
5. Holtzman, N. A. “Newborn Screening for Inborn Errors of Metabolism,” Pediatr. Clin. N. Amer. 25 (1978): 411-21.
6. Kaback, M. M. “Heterozygote Screening,” in Emery, A.E.H. and Rimoin, D. L., eds. The Principles and Practice of Medical Genetics. New York: Churchill Livingstone, 1990, pp. 1951-58.
7. Scriver, C. R., Kaufman, S., and Woo, S.L.C. “The Hyperphenylala-ninemias,” in Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D., eds. The Metabolic Basis of Inherited Disease. New York: McGraw Hill, 1989, PP* 495-546.
8. Dagenais, D. L., Courville, L., and Dagenais, M. G. “A Cost Benefit Analysis of the Quebec Network of Genetic Medicine,” Soc. Sci. Med. 20 (1985): 601-07.
9. Levy, H., personal communication.
10. Tuerck, J. M., Buist, N.R.M., Skeels, M. R., Hiyahira, R. S., and Beach, P. G. “Computerized Surveillance of Errors in Newborn Screening Practice,” Amer.J. Pub. Health 77 (1987): 1528-31.
11. Buist, N.R.M. “Laboratory Aspects of Newborn Screening for Metabolic Disorders,” Lab. Med. 19 (1988): 145-50.
12. Hill, A., Casey, R., and Zaleski, W. A. “Difficulties and Pitfalls in the Interpretation of Screening Tests for the Detection of Inborn Errors of Metabolism,” Clin. Chim. Acta 72 (1976): 1-15.
13. Sandhoff, K., Conzelmann, E., Neufeld, E. F., Kaback, M. M., and Suzuki, K. “The Gm2 Gangliosidoses,” in Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D., eds. The Metabolic Basis of Inherited Disease. New York: McGraw-Hill, 1989 pp. 1807-39.
14. Kaback, M. M., Nathan, T. J., and Greenwald, S. “Tay-Sachs Disease: Heterozygote Screening and Prenatal Diagnosis-U.S. Experience and World Perspective,” in Kaback, M. M., Rimoin, D. L., and O’Brien, J. S., eds. Tay-Sachs Disease: Screening and Prevention. New York: Alan R. Liss, Inc., 1977, pp. 13-36.
15. Boat, T. F., Welsh, M. J., and Beaudet, A. L. “Cystic Fibrosis,” in Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D., eds. The Metabolic Basis o f Inherited Disease. New York: McGraw-Hill, 1989, pp. 2649-80.
16. Rommens, J. M., Iannauzzi, M. C., Kerem, B-S., et al. “Identification of the Cystic Fibrosis Gene: Chromosome Walking and Jumping,” Science 245(1989): 1059-65.
17. Riordan, J. R., Rommens, J. M., Kerem, B-S., et al. “Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA,” Science 245 (1989): 1066-73.
18. Kerem, B-S., Rommens, J. M., Buchanan, J. A., et al. “Identification of the Cystic Fibrosis Gene: Genetic Analysis,” Science 245 (1989): 1073-80.
19. Highsmith, W. E., Chong, G. L., Orr, H. T., et al. “Frequency of the APhe$o8 Mutation and Correlation with XV.2C/KM-19 Haplotypes in an American Population of Cystic Fibrosis Patients: Results of a Collaborative Study,” Clin. Chem. 36 (1990): 1741-46.
20. Lemna, W. K., Feldman, G. L., Kerem, B-S., et al. “Mutation Analysis for Heterozygote Detection and the Prenatal Diagnosis of Cystic Fibrosis,” New Eng.J. Med. 322 (1990): 291-96.
21. Wilfond, B. S., and Fost, N. “The Cystic Fibrosis Gene: Medical and Social Implications for Heterozygote Detection,” J. Amer. Med. Assoc. 263(1990): 2777-83. ^
22. Billings, P. R., Kohn, M. A., de Cuevas, M., Beckwith, J., Alper, J. S., and Natowicz, M. R. “Discrimination as a Consequence of Genetic Testing,” Amer. J. Hum. Genet., in press.
23. Holtzman, N. A. Proceed with Caution: Predicting Genetic Risks in the Recombinant DNA Era. Baltimore: Johns Hopkins University Press, 1989.
24. Caskey, C. T., Kaback, M. M., and Beaudet, A. L. “The American Society of Human Genetics Statement on Cystic Fibrosis Screening,” Amer. J. Hum. Genet. 46 (1990): 393.
25. Workshop on Population Screening for the Cystic Fibrosis Gene. “Statement from the National Institutes of Health Workshop on Population Screening for the Cystic Fibrosis Gene,” New Eng. J. Med. 323 (1990): 70-71.
26. Nishimi, R. Y. “Forensic uses of DNA Tests,” J. Amer. Med. Assoc. 264 (1990): 2616.
27. Neufeld, P. J., and Colman, N. “When Science Takes the Witness Stand,” Scientific American 262 (1990): 46-53.
28. Lewin, R. “DNA Typing on the Witness Stand,” Science 244 (1989): 103-335
29. De Gorgey, A. “The Advent of DNA Databanks: Implication for Information Privacy,” Amer. J. Law Med. 41 (1990): 381-98.
30. Kolata, G. “Gene Test Barred as Proof in Court,” New York Times, Feb. 14, 1991, p. B12.
31. Office of Technology Assessment. Genetic Monitoring and Screening in the Workplace. Washington, D.C., 1990.
32. Daniels, C. R., Paul, M., and Rosofsky, R. “Health, Equity, and Reproductive Risks in the Workplace,” J. Pub. Health Policy 11 (1990): 449-62.